Role of the serotonergic system in reduced pulmonary function after exposure to methamphetamine

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 5, 2010, Pages 537-544

  Wells, Sandra M ^a   Buford, Mary C ^b   Porter, Virginia M ^b   Brunell, Heather L ^b   Bunderson Schelvan, Melisa ^b   Nevin, Andrew B ^b   Cardozo Pelaez, Fernando ^b   Holian, Andrij ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

Lung; Monoamine oxidase A; Selective serotonin reuptake inhibitor; Serotonin transporter

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; METHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; AMINE OXIDASE (FLAVIN CONTAINING); CITALOPRAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY PLETHYSMOGRAPHY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; IMMUNOFLUORESCENCE; IN VITRO STUDY; INHIBITION KINETICS; LUNG COMPLIANCE; LUNG FUNCTION; LUNG RESISTANCE; MOUSE; NONHUMAN; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; VAPOR; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; LUNG; LUNG FUNCTION TEST; METABOLISM; PHYSIOLOGY; TIME;

ANIMALIA; MURINAE; MUS;

ANIMALS; CITALOPRAM; EPITHELIAL CELLS; LUNG; METHAMPHETAMINE; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; MONOAMINE OXIDASE; RESPIRATORY FUNCTION TESTS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TIME FACTORS;

EID: 77951637232     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0121OC     Document Type: Article

References (37)

1. National Institute on Drug Abuse. Methamphetamine abuse and addiction. Bethesda, MD: National Institutes of Health; 2006.
2. National Drug Intelligence Center. National drug threat assessment 2007. Washington, DC: US Department of Justice; 2007.
3. Wells SM, Buford MC, Braseth SN, Hutchison JD, Holian A. Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice. Inhal Toxicol 2008;20:829-838. (Pubitemid 352032217)
4. Wiersma DA, Roth RA. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance. J Pharmacol Exp Ther 1980;212:97-102.
5. Lechin F, van der Dijs B, Orozco B, Lechin M, Lechin AE. Increased levels of free serotonin in plasma of symptomatic asthmatic patients. Ann Allergy Asthma Immunol 1996;77:245-253. (Pubitemid 26322585)
6. Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: a double-blind, crossover, placebo-controlled study. J Clin Pharmacol 1998;38:918-925. (Pubitemid 28482117)
7. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997;283:1305-1322.
8. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997;340:249-258. (Pubitemid 28022649)
9. Amara SG, Sonders MS. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 1998;51:87-96. (Pubitemid 28353758)
10. Strolin Benedetti M, Tipton KF. Monoamine oxidases and related amine oxidases as phase I enzymes in the metabolism of xenobiotics. J Neural Transm Suppl 1998;52:149-171. (Pubitemid 28175332)
11. Shih JC, Chen K, Ridd MJ. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999;22:197-217.
12. Molinoff PB, Axelrod J. Biochemistry of catecholamines. Annu Rev Biochem 1971;40:465-500.
13. Ulus IH, Maher TJ, Wurtman RJ. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Biochem Pharmacol 2000;59:1611-1621.
14. Zolkowska D, Rothman RB, Baumann MH. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther 2006;318:604-610. (Pubitemid 44061235)
15. Ameredes BT. Cardiac activity during airway resistance alterations with intravenous and inhaled methacholine. Respir Physiol Neurobiol 2004;139:281-292.
16. Archer AJ, Cramton JL, Pfau JC, Colasurdo G, Holian A. Airway responsiveness after acute exposure to urban particulate matter 1648 in a DO11.10 murine model. Am J Physiol Lung Cell Mol Physiol 2004;286:L337-L343. (Pubitemid 38129515)
17. Chong BT, Agrawal DK, Romero FA, Townley RG. Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. J Pharmacol Toxicol Methods 1998;39:163-168.
18. Glaab T, Ziegert M, Baelder R, Korolewitz R, Braun A, Hohlfeld JM, Mitzner W, Krug N, Hoymann HG. Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice. Respir Res 2005;6:139. (Pubitemid 41715985)
19. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-1150. (Pubitemid 32995372)
20. Lee SL, Fanburg BL. Serotonin uptake by bovine pulmonary artery endothelial cells in culture. II. Stimulation by hypoxia. Am J Physiol 1986;250:C766-C770.
21. Schwilke EW, Sampaio dos Santos MI, Logan BK. Changing patterns of drug and alcohol use in fatally injured drivers in Washington state. J Forensic Sci 2006;51:1191-1198.
22. Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study. Clin Pharmacol Ther 1998;64:223-232. (Pubitemid 28423858)
23. Lechin F, van der Dijs B, Jara H, Orozco B, Baez S, Benaim M, Lechin M, Lechin A. Effects of buspirone on plasma neurotransmitters in healthy subjects. J Neural Transm 1998;105:561-573. (Pubitemid 28454510)
24. Apparsundaram S, Stockdale DJ, Henningsen RA, Milla ME, Martin RS. Antidepressants targeting the serotonin reuptake transporter (SERT) act via a competitive mechanism. J Pharmacol Exp Ther 2008;327:982-990.
25. Rothman RB, Baumann MH. Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 2003;479:23-40.
26. Rudnick G, Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1993;1144:249-263. (Pubitemid 23290252)
27. Davis RB, Wang Y. Rapid pulmonary removal of 5-hydroxytryptamine in the intact dog. Proc Soc Exp Biol Med 1965;118:797-800.
28. Fowler JS, Logan J, Wang GJ, Franceschi D, Volkow ND, Telang F, Pappas N, Ferrieri R, Shea C, Garza V, et al. Monoamine oxidase A imaging in peripheral organs in healthy human subjects. Synapse 2003;49:178-187.
29. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 1996;93:14065-14069. (Pubitemid 26424246)
30. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Shea C, Garza V, Xu Y, et al. Comparison of monoamine oxidase A in peripheral organs in nonsmokers and smokers. J Nucl Med 2005;46:1414-1420.
31. Glaab T, Taube C, Braun A, Mitzner W. Invasive and noninvasive methods for studying pulmonary function in mice. Respir Res 2007;8:63.
32. Adler A, Cieslewicz G, Irvin CG. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol 2004;97:286-292.
33. Cazzola I, Matera MG. 5-HT modifiers as a potential treatment of asthma. Trends Pharmacol Sci 2000;21:13-16.
34. Kummer W, Wiegand S, Akinci S, Wessler I, Schinkel AH, Wess J, Koepsell H, Haberberger RV, Lips KS. Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse. Respir Res 2006;7:65.
35. Bhattacharya BK. A pharmacological study on the effect of 5-hydroxytryptamine and its antagonists on the bronchial musculature. Arch Int Pharmacodyn Ther 1955;103:357-369.
36. Islam MS, Melville GN, Ulmer WT. Role of atropine in antagonizing the effect of 5-hydroxytryptamine (5-HT) on bronchial and pulmonary vascular systems. Respiration 1974;31:47-59.
37. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Bockaert J, Marin P. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci USA 2007;104:8119-8124.